Program

SATURDAY JULY 23rd
Registration opens 4:00 pm
Keynote Opening Lecture 5:00 pm
Welcome reception 6:00 pm

FULL PROGRAM HERE FULL Program


Schedule at a glance
Molecular MR 2022 – Program Final-4
Oral Abstracts Part 1 MolMR 2022
Oral Abstracts Part 2 MolMR 2022 (updated 7/23)
Poster Abstracts MolMR 2022

Keynote Speaker:
Heike Daldrup-Link, Stanford University
Speakers:
Eric Ahrens, UC San Diego
Amnon Bar-Shir. Weizmann Institute
Rosa Tamara Branca, University of North Carolina
Veronica Clavijo Jordan, Martinos Center for Biomedical Imaging
Kazuya Kikuchi, Osaka University
Michael McMahon, Johns Hopkins University
Thomas Meade, Northwestern University
Arnab Mukherjee, UC Santa Barbara
Thomas Theis, NC State University
Jenny Yang, Georgia State University

*****You are required to be vaccinated on Caltech campus, it’s university policy.  We ask that you home test yourself the day before arrival and that you do not come to any conference lectures or activities if you are symptomatic.  If you become COVID-19 positive while at the conference, please let organizers know as soon as possible.  

PROGRAM

SATURDAY JULY 23RD

4:00     REGISTRATION OPENS

KEYNOTE LECTURE

5:00
Heiki Daldrup-Link
Monitoring Cancer Immunotherapy with Molecular MRI

RECEPTION TO FOLLOW

SUNDAY JULY 24TH

SESSION 1:  RESPONSIVE PROBES #1

 8:30
Thomas Meade
In Vivo Validation of Gene Expression and Tumor Resistance by MR Imaging

9:00
Robert Ohlendorf

Molecular brain imaging with engineered hemodynamics   

 Robert Ohlendorf,1 Miriam Schwalm,1 Alan Jasanoff,1

1Massachusetts Institute of Technology, Cambridge, MA

9:15
Yingying Ning

Molecular MRI for early detection of disease activity in liver fibrosis and response to treatment

Yingying Ning,1 Iris. Y. Zhou,1 Jesse D. Roberts,2 Nicholas J. Rotile,1 Eman Akam,1 Stephen C. Barrett,3 Mozhdeh Sojoodi,3 Matthew N. Barr,4 Tracy Punshon,4 Pamela Pantazopoulos,1 Hannah K. Drescher,5 Brian P. Jackson,4 Kenneth K. Tanabe,3 Peter Caravan1,*

1 Athinoula A. Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA, 2 Cardiovascular Research Center of the General Medical Services, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA, 3 Division of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA, 4 Department of Earth Sciences, Dartmouth College, Hanover, NH 03766, USA, 5 Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA

9:30
Elaine L Bearer
Imaging molecular functions in the brain with MR contrast agents 

E.L. Bearer, T.W. Uselman, H.B. Gray, and R.E. Jacobs

University of New Mexico Health Sciences Center, Albuquerque, NM; Beckman Institute, California Institute of Technology, Pasadena, CA, and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA

9:45
André Martins
Manganese-based blood pool T1 contrast-agent from a single pot template reaction

Anbu Sellamuthu, Sabrina Hoffmann, Fabio Carniato, Thomas Price, Lawrence Kenning, Timothy Prior, Mauro Botta3, Graeme Stasiuk, Andre F. Martins

Affiliations: 1-University Of Hull, HULL, United Kingdom; 2-University of Tübingen, Tübingen, Germany; 3-Università del Piemonte Orientale ‘A. Avogadro’, Dipartimento di Scienze e InnovazioneTecnologica, Alessandria, Italy; 4-King’s College London, Imaging Chemistry and Biology, London, United Kingdom; 5-Hull Royal Infirmary Hospital NHS Trust, Hull, United Kingdom, 6-Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Germany.

10:00               COFFEE BREAK

SESSION 2: IMAGING METABOLISM

10:30
Veronica Clavijo-Jordan
Imaging the Tumor Microenvironment by Multi-probe Molecular MRI

11:00
Anaïs Choffart
Hybrid visualization of cancer acidosis by non-invasive shift/acidoCEST MRI: The S2WTP3 vs. ML1B1B1 invasion quest. 

Anaïs Choffart 1, Remy Chiaffarelli 1, Sabrina L. Hoffmann 1, André F. Martins 1,2

  1. Werner Siemens Imaging Center,Department of Preclinical Imaging, University Hospital of Tübingen, Tübingen, Germany. 2. Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Germany.

11:15
Friederike Hesse
Imaging response to chemo-radiotherapy in glioblastoma tumour models using deuterium metabolic imaging

Friederike Hesse – University of Cambridge, CRUK CI, Cambridge, United Kingdom
Alan Wright – University of Cambridge, CRUK CI, Cambridge, United Kingdom
Vencel Somai – University of Cambridge, CRUK CI, Cambridge, United Kingdom, University of Cambridge, Radiology, Cambridge, United Kingdom,
Flaviu Bulat – University of Cambridge, CRUK CI, Cambridge, United Kingdom, University of Cambridge, Chemistry, Cambridge, United Kingdom
Kevin Brindle – University of Cambridge, CRUK CI, Cambridge, United Kingdom, University of Cambridge, Biochemistry, Cambridge, United Kingdom

11:30
Marta Vuozzo
Multiparametric MRI for tissue classification of subcutaneus MC38 colon cancer using oxygen enhanced, dynamic contrast enhancement (DCE) MRI and [18F]FAZA PET.        

Marta Vuozzo1,2, Max Zimmermann1, Remy Chiaffarelli1, Stefania Pezzana1, Bernd J. Pichler1,2 and Andreas M. Schmid1,2

1 Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University Hospital Tuebingen, Tuebingen, Germany. 2 Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Germany.

11:45
Eul Hyun Suh
Non-invasive Imaging of _-Cell Function in the Rat Pancreas by use of a Zinc-Responsive MRI Contrast Agent     

Eul Hyun Suh1, Bibek Thapa1, Daniel Parrott1,2, Pooyan Khalighinejad1, Gaurav Sharma1, Sara Chirayil1, and A. Dean Sherry1,2,3

1Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, Texas, United States, 2Department of Radiology, UT Southwestern Medical Center, Dallas, Texas, United States, 3Department of Chemistry, UT Dallas, Texas, United States.

12:00               LUNCH

SESSION 3: HYPERPOLARIZED MRI #1

1:00
Rosa Tamara Branca
Sensing the Heat with Spin Polarized Xe

1:30
Eduard Chekmenev
Next-generation Clinical-scale Instrumentation for Parahydrogen-Induced Polarization    

Shiraz Nantogma,1 Isaiah Adelabu,1 Nuwandi M. Ariasingha,1 Anna Samoilenko,1 Md Raduanul H. Chowdhury,1 Mohammad S. H. Kabir,1 Boyd M. Goodson,2 Eduard Y. Chekmenev1,3

1 Department of Chemistry, 3 Karmanos Cancer Institute (KCI), Integrative Biosciences (Ibio), Wayne State University, Detroit, Michigan, USA. 2 School of Chemical & Biomolecular Sciences, Materials Technology Center, Southern Illinois University, Carbondale, Illinois, USA

1:45
Ming Li Chia
Metabolic Signatures in High Grade Serous Ovarian Cancer (HGSOC)         

Ming Li Chia (1),Susana Ros (1),Alan Wright (1),Flaviu Bulat (1,2),Adam Gaunt (1) ,Maria Vias (1) Evis Sala (5),James Brenton (1,3,5), Kevin Brindle (1,4)

1)Cancer Research UK Cambridge, University of Cambridge, United Kingdom 2)Department of Chemistry, University of Cambridge, United Kingdom. 3)Department of Oncology, University of Cambridge, United Kingdom 4)Department of Biochemistry, University of Cambridge, United Kingdom 5)Cambridge University Hospital, Addenbrooke’s Hospital, United Kingdom

2:00
Lloyd Lumata
Feasibility and Challenges of In Vivo Hyperpolarized Imaging of MR Biosensors with Ultra-Low Gamma Nuclei   

Qing Wang,1 Jun Chen,2 Wirya Feizi,1 Asiye Asaadzade,1 Zoltan Kovacs,2 Jae Mo Park,2 and Lloyd Lumata1,3

1)UT Dallas Physics, 2)Advanced Imaging at UT Southwestern Medical Center, 3)UT Dallas Neuroscience

SESSION 4:  HETERONUCLEAR & CEST

2:30
Mike McMahon
The Advantages of Exogenous CEST Contrast Agents for Renal Imaging

 3:00
Elizabeth Kras
Fe(III) TACN-based Macrocycles with Various Pendant Donor Groups as MRI Probes         

Elizabeth A. Kras*, Rebecca P. Tarbox*, Janet R. Morrow*

*Department of Chemistry, University at Buffalo, State University of New York

3:15
Olivia Sehl
Imaging immune cells with fluorine-19 MRI 

Olivia C. Sehl1,2, Corby Fink1,3, Katherine MacDonald4, Veronica P. Dubois1,2, Marina Ninkov3, Mansour Haeryfar3, John A. Ronald1,2, Megan Levings4,5, Greg A. Dekaban1,3, Paula J. Foster1,2

1Robarts Research Institute, London, ON, 2Department of Medical Biophysics, Western University, London, ON, 3Department of Microbiology and Immunology, Western University, London, ON, 4School of Biomedical Engineering, The University of British Columbia, BC Children’s Hospital Research Institute, Vancouver, BC, 5Department of Surgery, The University of British Columbia, Vancouver, BC

3:30                 POSTER SESSION #1

5:00                 PANEL DISCUSSION #1

MONDAY JULY 25TH

SESSION 5: CEST (RESPONSIVE PROBES)

8:30
Amnon Bar-Shir
Computationally Designed Multicolored-MRI Reporter Genes

9:00
Remy Chiaffarelli
Extracellular Lactate Imaging with a New Generation of Lanthanide-based Shift Reagents and CEST MRI

Remy Chiaffarelli 1, Paul Jurek 3, Garry Kiefer 3, André F. Martins 1,2.

1- Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University Hospital Tuebingen, Tuebingen, Germany.  2- Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Germany.  3- Macrocyclics, Inc., Dallas, Texas, USA.

9:15
Behnaz Ghaemi         
Developing CESTheranostics by Enzyme-Mediated Intracellular Self-Assembly of Nanoparticles for Enhanced Imaging and Therapy of Prostate Cancer

Behnaz Ghaemi,a, Aruna Singh,b, Swati Tanwar,c, Yue Yuan,a, Ishan Barman,c, Michael T. McMahon,b and Jeff W. M. Bulte,a,b*

a, The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.  b, F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Inc., Baltimore, MD.  c, Department of Mechanical Engineering, Johns Hopkins University, Baltimore, MD.

10:00               COFFEE BREAK

SESSION 6: NANOMATERIALS #1

10:30
Kazuya Kikuchi
Nano-particle Based 19F MRI Contrast Agent with Tunable Chemical Switches

11:00
Mladen Barbic
High-Contrast-Ratio Tunable and Switchable MRI Labels using Magnetocaloric Materials

Mladen Barbic, NYU Langone Health – Tech4Health Institute, New York, NY, United States,

Stephen Dodd and Alan P. Koretsky, NIH/NINDS, Bethesda, MD, United States

11:15
Wei Wu
Molecular MRI can detect accumulation of CAR T-cells in GBM       

Wei Wu1,2, Edwin Chang1, Linchun Jin3, Shiqin Liu1, Rozy Kamal1, Nour Mary Aissaoui1, Laura Pisani1, Michael Moseley1, Tanya Stoyanova1, Jianping Huang3, Duane A. Mitchell3, and Heike E. Daldrup-Link1,4

  1. Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA. 2. Institute of Stem Cell Research and Regenerative Medicine, Stanford University, Stanford, CA, USA. 3. Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA. 4. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA

11:30
James Basilion
Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer    

Dong Luo1, Andrew Johnson2, Matthew Bailey2, Xinning Wang1, Clemens Burda3, Thomas J. Meade2, James P. Basilion1

1Department of Radiology, Case Western Reserve University, Cleveland, Ohio, United States, 2Department of Chemistry, Molecular Biosciences, Neurobiology, and Radiology, Northwestern University, Evanston, Illinois, United States, 3Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States

11:45
Ching-Hsin Huang
Cathepsin-Responsive Theranostic Nanoparticles for Image-Guided Glioblastoma Inhibition

Ching-Hsin Huang(1), Edwin Chang(1,2), Li Zhang(3), Joe Gerald Jesu Raj(1), Laura J. Pisani(1,4), and Heike Daldrup-Link(1)

(1) Molecular Imaging Program, Stanford University, United States;  (2) Canary Center, Stanford University, United States;  (3) ChemH, Stanford University, United States;  (4) James H. Clark Center, Stanford University, United States

12:00               LUNCH

SESSION 7: REPORTER GENES

 1:00
Arnab Mukherjee
Engineering Diffusion-based MRI Rporters with Low (or no) Background

1:30
Christian Farrar
Optimization of CEST reporter genes with a genetic programming Protein Optimization Evolving Tool     

Or Perlman1, Alexander R. Bricco2, E. Alejandro Castellanos2, Iliya Miralavy3, Shaowei Bo4, Tyler Gallagher5, Leo L. Cheng1, Michael T. McMahon4, Wolfgang Banzhaf3, Hiroshi Nakashima5, Assaf A. Gilad6,7, and Christian T. Farrar1

1Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA; 2Department of Biomedical Engineering, Michigan State University, East Lansing, MI; 3Department of Computer Science & Engineering, Michigan State University, East Lansing, MI; 5Department of Neurosurgery, Brigham & Women’s Hospital, Boston, MA; 4Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; 6Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI; 7Department of Radiology, Michigan State University, East Lansing, MI.

1:45
Sean McRae

The development of novel OATP1-targeted manganese-based MRI contrast agents

Sean W. McRae 1, Francisco M. Martinez 2 , Michael B. Cleary 3, Peter Caravan 3, Eric M. Gale 3, John A. Ronald 1, 2, Timothy J. Scholl 1, 2, 4

1: Department of Medical Biophysics, Western University, London, Ontario, Canada. , 2: Robarts Research Institute, Western University, London, Ontario, Canada. , 3: Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, United States.  4: Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

2:00
TianDuo Wang
Using synthetic notch to visualize cell-cell communication in vivo with magnetic resonance imaging       

TianDuo Wang (1,2), Yuanxin Chen (1), Nivin Nystrom (1,2), Shirley Liu (1,2), John. A. Ronald (1,2,3).

1.Robarts Research Institute – Imaging; , 2. Department of Medical Biophysics, University of Western Ontario; 3. Lawson Health Research Institute, London, ON, Canada.

2:15
Eva Toth
Mn2+-bispidines: a novel platform for Mn2+-based MRI agents     

Ndiaye,1 M. Sy,2 A. Nonat,2 L. Charbonnière, 2 P. Cieslik,3 P. Comba,3 E. Toth1

1Centre of Molecular Biophysics, CNRS, Orléans, France; 2. IPHC Strasbourg, France, 3. Univ. of Heidelberg, Germany

 

SESSION 8: HYPERPOLARIZED MRI #2

2:30
Thomas Theis
Parahydrogen Induced Polarization for Precision Measurement and Molecular Imaging

 3:00
Francesca Reineri
Towards fully biocompatible PHIP polarized pyruvate for in-vivo metabolic investigations

Francesca Reineri,1 Oksana Bondar,1 Carla Carrera2 and Silvio Aime1

1Torino University, Dept. Molecular Biotechnology and Health Sciences, Via Nizza 52, Torino, Italy, 2Institute of Biostructures and Bioimaging National Research Council Via Nizza 52, 10126 Torino (Italy)

3:15
Cuihua Wang
Development of an MRI agent to detect CD206 and M2-like macrophages

Cuihua Wang1,2, Negin Jalali Motlagh1,2, Gregory R. Wojtkiewicz2, John W. Chen1,2

1Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, 2Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.

3:30                 POSTER SESSION #2

5:00                 DISCUSSION PANEL #2


TUESDAY JULY 26TH

SESSION 9: RESPONSIVE PROBES #2

8:30
Jenny Yang
Key Molecular Determinants for Chronic Diseases

 9:00
Célia Bonnet
Zinc detection by MRI using a lanthanide complex-zinc finger peptide conjugate   

Agnès Pallier, Frédéric Szeremeta, Célia Bonnet, Centre de Biophysique Moléculaire, UPR 4301 CNRS, rue Charles Sadron, 45071 Orléans, France; Manon Isaac, Olivier Sénèque Université Grenoble Alpes, CNRS CEA, BIG, LCBM, Avenue des Martyrs, 38000 Grenoble, France; Laurent Barantin Université de Tours, UMR1251, iBrain, Tours, France

9:15
Eric Gale
Precision Magnetic Resonance Imaging of Kidney Inflammation     

Mozhdeh Sojoodi,1 Ivy Rosales,2 Ilknur Ay,3 Kenneth K. Tanabe,1 Peter Caravan,3 Veronica Clavijo Jordan,3 Iris Yuwen Zhou,3 Eric M. Gale3

Departments of Surgical Oncology (1) Pathology (2), and A.A. Martinos Center for Biomedical Imaging and Institute for Innovation in Imaging, Radiology (3), Massachusetts General Hospital, Harvard Medical School.

9:30
Christian Goldsmith
The development of highly water-stable MRI contrast agent sensors for hydrogen peroxide

Christian R. Goldsmith, Sana Karbalaei, Ronald J. Beyers

9:45
Janet Morrow
Redox-responsive transition metal MRI probes: from liposomes to small molecules           

Janet R. Morrow(1) , Md Saiful I. Chowdhury(1), Jaclyn Raymond(1), Joseph Spernyak(2)

1)Chemistry Department, The State University of New York at Buffalo, New York, 14260, USA 2)Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, USA

10:00               COFFEE BREAK

SESSION 10: NANOMATERIALS #2

10:30
Erik Ahrens
Multimodal Imaging Using Functionalized Fluorocarbon Nanoemulsions

 11:00
Ali Shakeri-Zadeh
MPI/MRI of cerebral homing of SPIO-labeled stem cells after intra-arterial injection         

  1. Shakeri-Zadeh1,2, S. Kuddannaya1,2, A. Bibic1,3, P Walczak4, and J.W.M. Bulte1,2,3*

1The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, Baltimore, MD, USA; 2Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, Baltimore, MD, USA; 3F.M. Kirby Research Center for Functional Brain Imaging, Hugo W. Moser Institute, Kennedy Krieger Inc., Baltimore, MD, USA;  4Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.  *Corresponding author, email: jwmbulte@mri.jhu.edu.

11:15
Gregory Sokolow
Exploring the use of Iron(III) Metal-Organic Polyhedra as Magnetic Resonance Imaging Contrast Agents for Murine Tumor Models      

Gregory E. Sokolow,1 Matthew R. Crawley,1 Joseph A. Spernyak,2 Timothy R. Cook,1 and Janet R. Morrow1

1.Department of Chemistry, University at Buffalo the State University of New York, Buffalo, NY 14260. 2. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263.

11:30
Chao Wang
All-in-one superparamagnetic radiopaque nanocomplex for in vivo MRI, MPI, and CT stem cell tracking  

  1. Wang1,2, A. Shakeri-Zadeh1,2, S. Kuddannaya1,2, and J.W.M. Bulte1,2*

1The Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, Baltimore, MD, USA; 2Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, Baltimore, MD, USA.*Corresponding author, email: jwmbulte@mri.jhu.edu

11:45
Dongjun Li
Novel Collagen-targeted Protein MRI Contrast Agent for Noninvasive Detection of Fibrosis and Cancer

Dongjun Li1, Zongxiang Gui1, Jingjuan Qiao1, Brenda-Ruth Mimba1, Florence N. Reddish1, Van Ha1, Odubade Oluwatosin1, Hua Yang2, Khan Hekmateyar1, Mani Salarian1, Ravi Chakra3, Zhiren Liu3, Shirong Wang3, Hang Shi3, Bingzhong Xue3, Hans E. Grossniklaus2, Jenny J. Yang 1

1Department of Chemistry, Center for Diagnostics and Therapeutics, Advanced Translational Facility, Georgia State University, Atlanta, GA 30303, USA.  2Department of Ophthalmology, Emory University, Atlanta, GA 30322, USA. 3Department of Biology, Georgia State University, Atlanta, GA 30303, USA.

12:00               LUNCH

SESSION 11: RESPONSIVE PROBES #3

1:00
Benjamin Bartelle
Molecular tools to resolve neuroimmune signaling with MRI           

1:15
Hua Ma

Mn(II)-based allysine-targeted molecular MR probes for imaging pulmonary fibrogenesis

Hua Ma1, Iris Y. Zhou1, Matthew Drummond2, Nicholas Rotile1, Rachel Knipe2, Huan Wang1, Eman Akam1, Peter Caravan1

1Athinoula A. Martinos Center for Biomedical Imaging, Institute for Innovation in Imaging (i3), Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA, 2Division of Pulmonary and Critical Care Medicine and the Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.

1:30
Zongxiang Gui
Non-invasive Mapping of molecular determinants for Liver cancer and metastatic aggressiveness by Precision MRI (pMRI)       

Zongxiang Gui, Shanshan Tan, Jingjuan Qiao, Dongjun Li, Tosin Ibhagui, Hua Yang, Khan Hekmatyar, Yuguang Meng, Nan Wang, Yibin Xie, Phillip Zhe Sun, Ekihiro Seki, Debiao Li, Hans E. Grossniklaus, Jenny J. Yang

Department of Chemistry, Advanced Translational Imaging Facility, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, USA, Department of Ophthalmology, Emory University, Atlanta, GA 30322, USA, Yerkes National Primate Research Center, Atlanta, GA, 30329, USA, Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA, Department of Bioengineering, University of California, Los Angeles, CA 90095, USA, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

1:45
Shreyas Kuddannaya
Monitoring Scaffolded Glial-Restricted Progenitor Cell Survival and Hydrogel Degradation in the CNS of ALS mice          

Shreyas Kuddannaya (1), Sarah K. Gross (2), Nicholas J. Maragakis (2), Jeff W.M. Bulte (1)

1Cellular Imaging Section, Institute for Cell Engineering and Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University SOM, Baltimore, MD, USA, 2Department of Neurology, Johns Hopkins University SOM, Baltimore, MD

2:00
PANEL DISCUSSION
The Future of Molecular MR